Profile
Marcel Zwaal worked as Chief Executive Officer at Hubrecht Organoid Technology Foundation from 2016 to 2017.
Served as Senior Vice President-Corporate Development at Kiadis Pharma NV from 2018 to 2020.
Held the position of Chief Executive Officer at Gadeta BV from 2021 to 2023.
Occupied roles including Chief Executive Officer at DCPrime BV, Director-Business Control & Planning at Crucell NV, and Internal Auditor at Philips Electronics Nederland BV.
Completed graduate education at Vrije Universiteit Amsterdam.
Former positions of Marcel Zwaal
| Companies | Position | End |
|---|---|---|
Gadeta BV
Gadeta BV BiotechnologyHealth Technology Conducts research and develops medicines & treatment methods for cancer | Chief Executive Officer | 2023-09-30 |
| KIADIS PHARMA N.V. | Corporate Officer/Principal | 2020-07-12 |
Hubrecht Organoid Technology Foundation | Chief Executive Officer | 2017-11-30 |
Philips Electronics Nederland BV
Philips Electronics Nederland BV Real Estate DevelopmentFinance Owns, operates and leases nonresidential buildings | Corporate Officer/Principal | - |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies | Corporate Officer/Principal | - |
Training of Marcel Zwaal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies | Health Technology |
Vrije Universiteit Amsterdam
Vrije Universiteit Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philips Electronics Nederland BV
Philips Electronics Nederland BV Real Estate DevelopmentFinance Owns, operates and leases nonresidential buildings | Finance |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology Provides therapeutic vaccines for the treatment of cancer | Health Technology |
Kiadis Pharma NV
Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products | Health Technology |
Gadeta BV
Gadeta BV BiotechnologyHealth Technology Conducts research and develops medicines & treatment methods for cancer | Health Technology |
Hubrecht Organoid Technology Foundation |
- Stock Market
- Insiders
- Marcel Zwaal
















